Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Camurus, Sinclair IS Pharma, Teva sales and marketing update

Sinclair returned the majority of commercialization rights in Europe for Episil oral spray to Camurus. Sinclair, which

Read the full 176 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE